SCM Lifescience Co., Ltd. (KOSDAQ:298060)

SCM Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	114.32	49.59	4,496	6,916	2,890	77.47
Short-Term Investments	2,600	870.16	7,840	2,053	16,754	35,219
Cash & Short-Term Investments	2,714	919.76	12,336	8,970	19,644	35,297
Cash Growth	-71.47%	-92.54%	37.52%	-54.34%	-44.35%	46.95%
Accounts Receivable	530.73	48.8	106.41	5.63	16.8	18.59
Other Receivables	28.68	86.81	19.91	19.7	72.87	59.18
Receivables	559.4	135.62	126.32	25.34	89.66	77.77
Inventory	417.92	535.02	392.06	102.71	279.68	36.02
Prepaid Expenses	437.72	283.65	264.78	227.82	223	311.73
Other Current Assets	138.23	122.03	141.25	714.15	75.52	363.66
Total Current Assets	4,268	1,996	13,260	10,040	20,312	36,086
Property, Plant & Equipment	24,369	20,450	10,254	10,650	11,117	11,544
Long-Term Investments	-	-	1,085	11,468	21,654	28,167
Other Intangible Assets	699.34	695.97	236.93	302.73	335.32	359.17
Other Long-Term Assets	18.56	27.28	567.69	559.11	627.01	136.21
Total Assets	29,355	23,170	25,404	33,020	54,045	76,292
Accrued Expenses	169.97	180.63	180.44	107.3	232.79	224.61
Short-Term Debt	-	-	-	2,000	-	-
Current Portion of Long-Term Debt	3,630	3,630	-	-	5,820	120
Current Portion of Leases	50.14	160.06	131.05	61.56	269.68	330.72
Other Current Liabilities	1,636	1,770	836.73	2,393	2,387	2,584
Total Current Liabilities	5,486	5,741	1,148	4,562	8,709	3,259
Long-Term Debt	3,150	3,150	3,630	3,630	-	5,820
Long-Term Leases	26.32	26.32	57.02	77.55	81.12	368.64
Other Long-Term Liabilities	73.84	73.84	95.01	239.21	641.8	3,765
Total Liabilities	8,737	8,991	4,930	8,509	9,432	13,213
Common Stock	13,870	10,234	10,234	6,060	6,011	5,937
Additional Paid-In Capital	182,920	178,577	178,514	163,098	161,784	160,144
Retained Earnings	-184,904	-183,364	-170,987	-147,026	-124,096	-101,577
Treasury Stock	-16.56	-16.56	-16.56	-	-	-
Comprehensive Income & Other	8,749	8,749	2,730	2,378	913.54	-1,425
Total Common Equity	20,618	14,179	20,474	24,511	44,613	63,079
Shareholders' Equity	20,618	14,179	20,474	24,511	44,613	63,079
Total Liabilities & Equity	29,355	23,170	25,404	33,020	54,045	76,292
Total Debt	6,857	6,966	3,818	5,769	6,171	6,639
Net Cash (Debt)	-4,142	-6,047	8,518	3,201	13,473	28,658
Net Cash Growth	-	-	166.12%	-76.24%	-52.99%	69.77%
Net Cash Per Share	-186.42	-295.53	520.41	220.68	1126.01	2701.30
Filing Date Shares Outstanding	27.5	20.46	20.46	14.54	14.43	14.25
Total Common Shares Outstanding	27.5	20.46	20.46	14.54	14.43	14.25
Working Capital	-1,219	-3,745	12,112	5,478	11,602	32,827
Book Value Per Share	749.63	692.98	1000.63	1685.22	3092.46	4426.77
Tangible Book Value	19,919	13,483	20,237	24,208	44,277	62,720
Tangible Book Value Per Share	724.20	658.97	989.05	1664.40	3069.22	4401.57
Land	15,023	13,648	6,967	6,967	6,967	6,967
Buildings	5,329	2,117	2,117	2,117	2,117	2,114
Machinery	3,590	3,590	3,561	3,472	3,318	2,762
Construction In Progress	4,028	4,498	640.2	577.31	304.92	293.57

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.